Evaluating Service Delivery Models for Prevention of Mother-to-Child Transmission of HIV


Since the late 1990s, by providing services to prevent mother-to-child transmission of HIV, many countries have made significant progress toward eliminating new HIV infections in children. The introduction and rollout of Option B+ was a contributing factor in these achievements and an important step toward achieving an AIDS-free generation. Nonetheless, access to antiretroviral treatment (ART) and retention in care remain challenges. Given the low levels of PMTCT service coverage, many governments and development organizations are reaching out to nontraditional partners, including the private for-profit sector, community-based organizations (CBOs), and civil society organizations (CSOs), to scale up and expand access to PMTCT services.

This literature review compares PMTCT programs implemented by CSOs with those implemented by public sector providers and the private, commercial sector, in order to determine the relative cost-effectiveness of each facility ownership model.

March 29, 2016
Year of publication
Resource types
Literature review
HIV prevention, PMTCT, prevention of mother-to-child transmission (PMTCT), public sector, Option B +, retention in care, treatment, ARVs, antiretroviral therapy, antiretroviral drugs, ART, civil society organizations (CSOs), community-based organizations (CBOs), service delivery

Similar Resources

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

To understand the uptake of HIV services by adolescent women, the authors conducted a retrospective analysis of patient-level data (2011–2013) on services for antenatal care (ANC) and prevention of mother-to-child transmission (PMTCT) in 36 facilities in 5 districts in Zimbabwe.

This study aimed to evaluate the impact of clinic-based prevention of mother-to-child transmission (PMTCT) community support by trained lay health workers in addition to standard clinical care on PMTCT infant outcomes.

An essential first step in caring for HIV-infected children is accurate and early diagnosis of HIV, early HIV testing, prompt return of results, and rapid initiation of treatment.

Universal antiretroviral therapy (ART) for all pregnant/ breastfeeding women living with HIV, known as prevention of mother-to-child transmission of HIV (PMTCT) Option B+ (PMTCTB+), is being scaled up in most countries in Sub-Saharan Africa.

Baylor-Malawi, with USAID funding, has developed a special JAIDS supplement featuring 11 articles which highlight lessons and best practices from the Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative, a public-private partnership that expanded pediatric HIV services in nine sub-Saharan

Background: The recent scale-up of prevention of mother-to-child transmission of HIV (PMTCT) services has rapidly accelerated antiretroviral therapy (ART) uptake among pregnant and postpartum women in sub-Saharan Africa.

The Accelerating Children’s HIV/AIDS Treatment (ACT) Initiative was a public-private partnership that expanded pediatric HIV services in nine sub-Saharan African countries from 2014-2016, providing treatment to more than 560,000 children living with HIV.

Initiation of antiretroviral therapy (ART) following diagnosis of HIV infection at birth is an emerging area of paediatric HIV care. We present outcomes of HIV-infected infants identified at birth at Rahima Moosa Mother and Child Hospital in Johannesburg, South Africa.

Across sub-Saharan Africa, prevention of mother-to-child transmission services are encountering increasing numbers of women already established on antiretroviral therapy (ART) when entering antenatal care.